Unique redox properties of motexafin gadolinium (MGD)

被引：0
|
作者：
Biaglow, J
Magda, D
机构：
[1] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[2] Pharmacycl Inc, Sunnyvale, CA 94085 USA
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
28
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] Biologic properties and clinical results with motexafin gadolinium (MGD): A tumor selective redox mediator
    Miller, R
    Magda, D
    Phan, S
    Renschler, M
    Mehta, M
    FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 : S134 - S134
  • [2] In vitro identification and characterization of the metabolism of motexafin gadolinium (MGD)
    Mani, C
    Fu, L
    Miles, D
    Boswell, G
    DRUG METABOLISM REVIEWS, 2003, 35 : 186 - 186
  • [3] Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd)
    Avval, Farnaz Zahedi
    Berndt, Carsten
    Pramanik, Aladdin
    Holmgren, Arne
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (03) : 775 - 779
  • [4] Evaluation of motexafin gadolinium (MGd) as a contrast agent for Intraoperative MRI
    Hirschberg, H.
    Wo, G. N.
    Madsen, S. J.
    MINIMALLY INVASIVE NEUROSURGERY, 2007, 50 (06) : 318 - 323
  • [5] Redox chemistry of motexafin gadolinium with ascorbate and GSH
    Martin, SM
    Holland, CL
    Schafer, FQ
    Buettner, GR
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S442 - S442
  • [6] Enzymatic pathways involved in the metabolism of motexafin gadolinium (MGd) in rat and human liver
    Mani, C
    Jejurkar, P
    Miles, D
    Boswell, G
    DRUG METABOLISM REVIEWS, 2004, 36 : 103 - 103
  • [7] Phase I and pharmacodynamic study of motexafin gadolinium (MGd) in combination with doxorubicin (Dox).
    Thomas, JP
    Wilding, G
    Egorin, M
    Bailey, H
    Alberti, D
    Tutsch, K
    Marnocha, R
    Chatta, K
    Tutchko, S
    Renschler, M
    Ramanathan, R
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6201S - 6201S
  • [8] A phase I trial of combination motexafin gadolinium (MGD) and temozolomide in malignant gliomas
    Shapiro, W. R.
    Ashby, L. S.
    Phan, S.
    NEURO-ONCOLOGY, 2006, 8 (04) : 451 - 452
  • [9] Motexafin gadolinium (MGd) is cytotoxic to steroid and chemotherapy-resistant myeloma cell lines: Striking enhancment of apoptosis by redox regulation.
    Evens, AM
    Prachand, S
    Gartenhaus, R
    Miller, R
    Gordon, LI
    BLOOD, 2002, 100 (11) : 380B - 380B
  • [10] Chemistry, biochemistry, and biologic properties of motexafin gadolinium: A tumor selective redox mediator.
    Magda, DJ
    Miller, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U756 - U757
12345